Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry

Nudrat Noor 1, Osagie Ebekozien 2 3, Laura Levin 4, Sheri Stone 5, David P Sparling 6, Robert Rapaport 7, David M Maahs 8

Affiliations

1. Quality Improvement and Population Health, T1D Exchange, Boston, MA nnoor@t1dexchange.org.
2. Quality Improvement and Population Health, T1D Exchange, Boston, MA.
3. University of Mississippi Medical Center, Jackson, MS.
4. Lurie Children Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL.
5. State University of New York Upstate Medical University, Syracuse, NY.
6. Harold Hamm Diabetes Center, University of Oklahoma College of Medicine, Oklahoma City, OK.
7. Icahn School of Medicine at Mount Sinai, New York, NY.
8. Lucile Packard Children’s Hospital, Stanford University School of Medicine, Stanford, CA.

PMID: 34385347 DOI: 10.2337/dc21-0074

Click here to go to PubMed